NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.33%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$21.8M
(+2.2%)
Cap. Flow
-$93.3M
Cap. Flow
% of AUM
-9.14%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
137
New
19
Increased
22
Reduced
37
Closed
18
Top Buys
| 1 |
Peloton Interactive
PTON
|
$13.1M |
| 2 |
Tourmaline Bio
TRML
|
$6.64M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$6.6M |
| 4 |
eHealth
EHTH
|
$5.55M |
| 5 |
CONN
Conn's Inc.
CONN
|
$4.73M |
Top Sells
| 1 |
Establishment Labs
ESTA
|
$25.7M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$19.7M |
| 3 |
Soleno Therapeutics
SLNO
|
$19.1M |
| 4 |
Luxfer Holdings
LXFR
|
$11.7M |
| 5 |
Cytokinetics
CYTK
|
$9.19M |
Sector Composition
| 1 | Healthcare | 63.23% |
| 2 | Consumer Discretionary | 13.84% |
| 3 | Financials | 7.05% |
| 4 | Communication Services | 5.88% |
| 5 | Technology | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Syndax Pharmaceuticals
SNDX
$1.47B
| $11.1M | 0.63% |
465,259
+100,000
| +27% | +$2.38M |
|
27
Aura Biosciences
AURA
$403M
| $10.4M | 0.59% |
1,321,860
| – | – |
|
28
Neuropace
NPCE
$322M
| $10.3M | 0.59% |
778,260
-395,417
| -34% | -$5.22M |
|
29
Golden Entertainment
GDEN
$649M
| $9.92M | 0.57% |
269,267
-22,182
| -8% | -$817K |
|
30
Assertio
ASRT
$76.8M
| $8.89M | 0.51% |
9,270,836
+1,651,396
| +22% | +$1.58M |
|
31
Payoneer
PAYO
$2.4B
| $8.85M | 0.51% |
1,821,426
+74,022
| +4% | +$360K |
|
32
Savara
SVRA
$643M
| $8.65M | 0.49% |
1,737,410
+749,507
| +76% | +$3.73M |
|
33
Unicycive Therapeutics
UNCY
$77M
| $8.64M | 0.49% |
333,559
-10,259
| -3% | -$266K |
|
34
The RMR Group
RMR
$284M
| $8.3M | 0.47% |
345,792
-58,271
| -14% | -$1.4M |
|
35
Immatics
IMTX
$761M
| $8.28M | 0.47% |
787,974
-625,982
| -44% | -$6.58M |
|
|
ILPT
36
Industrial Logistics Properties Trust
ILPT
$407M
| $8.07M | 0.46% |
1,881,132
-111,687
| -6% | -$479K |
|
37
VistaGen Therapeutics
VTGN
$109M
| $8.01M | 0.46% |
1,517,696
-299,034
| -16% | -$1.58M |
|
38
Rezolute
RZLT
$696M
| $7.71M | 0.44% |
3,022,947
+1,485,240
| +97% | +$3.79M |
|
39
Noodles & Co
NDLS
$31.1M
| $7.7M | 0.44% |
4,033,329
+288,758
| +8% | +$552K |
|
40
Cellectar Biosciences
CLRB
$15.9M
| $7.46M | 0.43% |
62,444
+17,425
| +39% | +$2.08M |
|
|
41
Luxfer Holdings
LXFR
$367M
| $7.11M | 0.41% |
685,253
-1,124,392
| -62% | -$11.7M |
|
42
NN Inc
NNBR
$125M
| $6.67M | 0.38% |
1,406,446
-776
| -0.1% | -$3.68K |
|
|
EGRX
43
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.6M | 0.38% |
+1,258,762
| New | +$6.6M |
|
44
Reading International Class A
RDI
$33.8M
| $6.23M | 0.36% |
3,385,253
-16,950
| -0.5% | -$31.2K |
|
45
TELA Bio
TELA
$63M
| $6.22M | 0.36% |
1,097,866
| – | – |
|
46
Zynex
ZYXI
$45.1M
| $6.06M | 0.35% |
490,000
+370,000
| +308% | +$4.58M |
|
|
CONN
47
DELISTED
Conn's Inc.
CONN
| $5.93M | 0.34% |
1,769,997
+1,410,626
| +393% | +$4.73M |
|
48
Tarsus Pharmaceuticals
TARS
$2.43B
| $5.46M | 0.31% |
150,321
-224,955
| -60% | -$8.18M |
|
49
Cogent Biosciences
COGT
$1.82B
| $5.32M | 0.3% |
790,936
+150,000
| +23% | +$1.01M |
|
50
Alta Equipment Group
ALTG
$275M
| $5.21M | 0.3% |
402,509
+100,000
| +33% | +$1.3M |
|